SKYRIZI
SKYRIZI®
Skyrizi® (risankizumab-rzaa) is an intravenous infusion given every 4 weeks x 3 doses indicated for the treatment of moderately to severely active Crohn’s disease.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
